11,846 Shares in Viemed Healthcare, Inc. (NASDAQ:VMD) Purchased by Walleye Capital LLC

Walleye Capital LLC acquired a new position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 11,846 shares of the company’s stock, valued at approximately $87,000.

Several other large investors have also made changes to their positions in the business. Penbrook Management LLC raised its holdings in Viemed Healthcare by 236.0% in the 2nd quarter. Penbrook Management LLC now owns 231,607 shares of the company’s stock valued at $1,517,000 after acquiring an additional 162,670 shares in the last quarter. Apis Capital Advisors LLC grew its stake in shares of Viemed Healthcare by 193.0% in the 2nd quarter. Apis Capital Advisors LLC now owns 234,400 shares of the company’s stock valued at $1,535,000 after purchasing an additional 154,400 shares during the period. Renaissance Technologies LLC grew its stake in shares of Viemed Healthcare by 50.9% in the 2nd quarter. Renaissance Technologies LLC now owns 438,700 shares of the company’s stock valued at $2,873,000 after purchasing an additional 147,900 shares during the period. Victory Capital Management Inc. grew its stake in shares of Viemed Healthcare by 748.2% in the 3rd quarter. Victory Capital Management Inc. now owns 108,497 shares of the company’s stock valued at $795,000 after purchasing an additional 95,706 shares during the period. Finally, Paradigm Capital Management Inc. NY grew its stake in shares of Viemed Healthcare by 25.0% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 400,000 shares of the company’s stock valued at $2,620,000 after purchasing an additional 80,000 shares during the period. Institutional investors and hedge funds own 74.24% of the company’s stock.

Viemed Healthcare Trading Down 2.5 %

VMD stock opened at $8.68 on Friday. Viemed Healthcare, Inc. has a 1-year low of $6.21 and a 1-year high of $10.44. The firm has a market cap of $338.00 million, a P/E ratio of 32.15 and a beta of 1.46. The business’s 50 day moving average is $8.84 and its 200-day moving average is $7.71. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The company had revenue of $58.00 million for the quarter.

Insider Buying and Selling

In other Viemed Healthcare news, Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total value of $336,502.08. Following the transaction, the director now directly owns 107,706 shares in the company, valued at approximately $999,511.68. This trade represents a 25.19 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Nitin Kaushal sold 30,000 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $9.56, for a total value of $286,800.00. Following the completion of the transaction, the director now owns 126,843 shares in the company, valued at $1,212,619.08. The trade was a 19.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 72,256 shares of company stock worth $674,739 in the last three months. Insiders own 20.00% of the company’s stock.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.